Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stress

Abstract

BackgroundLike normal hematopoietic stem cells, leukemia cells proliferate in bone marrow, where oxygen supply is limited. However, the growth and energy metabolism of leukemia cells under hypoxia have not been well understood. Although it has been known that reactive oxygen species (ROS) is generated under hypoxic conditions, normal and leukemia stem cells were characterized by relatively low levels of ROS. Roles of ROS on leukemia cells under hypoxia also have not been well understood.MethodsFour Leukemia cell lines were cultured under normoxia (21% O2) or hypoxia (1% O2), where NB4 and THP-1 were most extensively studied. To evaluate energy metabolism, we estimated whole cell number or apoptotic cells with or without a glycolysis inhibitor or an oxidative phosphorylation (OXPHOS) inhibitor. Glucose consumption and lactate production were also measured. To evaluate oxidative stress in hypoxic condition, the ROS level and GSH (reduced glutathione) / GSSG (oxidized glutathione) ratio was measured. In addition, pyruvate dehydrogenase kinase 1 (PDK1) and cytochrome c oxidase subunit 4 (COX4) were examined by western blotting or RT-PCR.ResultsNB4, which grows well under normoxia depending on glycolysis, demonstrated prominent apoptosis and growth suppression after 48 hours culture under hypoxia. NB4 cells cultured under hypoxia showed significantly increased ROS. Culture with a ROS scavenger resulted in decrease of apoptotic cell death of NB4 under hypoxia. NB4 cells cultured for longer period (7 days) under hypoxia did not come to extinction, but grew slowly by upregulating GSH synthesis to protect from ROS generated in hypoxic condition. By contrast, THP-1, which largely depends on OXPHOS in mitochondria under normoxia, demonstrated more growth under hypoxia by changing metabolism from OXPHOS to glycolysis through upregulating PDK1. Moreover, THP-1 avoided ROS generation by substituting COX 4 subunit (from COX 4–1 to COX 4–2) through upregulation of LON, a mitochondrial protease under hypoxia.ConclusionsWe showed that leukemia cells survive and adapt to the hypoxic condition through various pathways. Our results will help understanding energy metabolism of leukemia cells and creating novel therapeutics.

Differential hypoxic regulation of the microRNA-146a/CXCR4 pathway in normal and leukemic monocytic cells: impact on response to chemotherapy

“…Leukemic cells survive by adapting their metabolism to hypoxic conditions. 45 This adaptation to hypoxia is primarily mediated by two closely related hypoxia-inducible transcription factors, HIF-1α and HIF-2α, broadly expressed in many human cancers and frequently correlated with a poor prognosis. HIF-1α and HIF-2α exhibit shared or unique activities in processes that affect tumor growth and metastasis related to their targets genes, such as CXCR4 and its ligand SDF-1/CXCL12, 9-11 but also microRNA.…”

Reactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotype

“…Treatment with the antioxidant NAC enhanced metastatic burden but not growth of subcutaneous tumors, suggesting they have lower ROS. Different cell lines demonstrate different methods of combating stress . We propose that cancer cells may reduce ROS through three primary mechanisms.…”

Study of antioxidant properties of thylakoids and application in UV protection and repair of UV‐induced damage

“…Electrons can quickly interact with molecular oxygen to form superoxide anion (O 2 ‐) and cause cell damage. CellROX is a fluorogenic dye specifically targeted to assay live cells to indicate superoxide levels …”

“…In the proliferation and cytotoxicity assays, 2 × 10 4 cells per well were plated in 96‐multiwell plate. Thus, concentration of 0.2 mg/mL and below can be used for the CellROX oxidative stress assays in THP‐1 cells …”